scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41540-017-0033-0 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41540-017-0033-0 |
P932 | PMC publication ID | 5676686 |
P698 | PubMed publication ID | 29138692 |
P50 | author | Anirikh Chakrabarti | Q58804442 |
Sylviane Metairon | Q87816892 | ||
Frederic Raymond | Q92162858 | ||
P2093 | author name string | Hugues Henry | |
Bertrand Betrisey | |||
Delphine Morin-Rivron | |||
Mojgan Masoodi | |||
Mathieu Membrez | |||
Stephen Bruce | |||
Chieh Jason Chou | |||
Jay Siddharth | |||
Scott J Parkinson | |||
Carole Loyer | |||
P2860 | cites work | LipidHome: a database of theoretical lipids optimized for high throughput mass spectrometry lipidomics | Q21133551 |
Insulin signalling and the regulation of glucose and lipid metabolism | Q24292020 | ||
KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
BASys: a web server for automated bacterial genome annotation | Q24530556 | ||
LMPD: LIPID MAPS proteome database | Q24538668 | ||
A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences | Q27323971 | ||
Expanding role of gut microbiota in lipid metabolism | Q28066694 | ||
Using Genome-scale Models to Predict Biological Capabilities | Q28085366 | ||
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 | Q28246991 | ||
The role of phospholipases A2 in schizophrenia | Q28305324 | ||
Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity | Q28316989 | ||
Context-specific metabolic networks are consistent with experiments | Q28472711 | ||
Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production | Q28475985 | ||
Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INIT | Q28483779 | ||
An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids | Q28611371 | ||
Applications of genome-scale metabolic reconstructions | Q29031028 | ||
Host-gut microbiota metabolic interactions | Q29615104 | ||
Functional integration of a metabolic network model and expression data without arbitrary thresholding. | Q30452532 | ||
Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment | Q30945619 | ||
Integration of gene expression data into genome-scale metabolic models | Q30970854 | ||
Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli | Q31151969 | ||
Optical mapping as a routine tool for bacterial genome sequence finishing | Q33299015 | ||
Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut | Q33665593 | ||
Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism | Q33814929 | ||
Identification of a glycoprotein produced by enterotoxigenic Escherichia coli | Q34001475 | ||
Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier | Q34177395 | ||
Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis. | Q34200286 | ||
Improving metabolic flux predictions using absolute gene expression data | Q34309177 | ||
Identification of a domain in Yersinia virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake | Q34480030 | ||
Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndrome | Q34489621 | ||
Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE | Q34509501 | ||
Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus | Q34570007 | ||
Informatics and computational strategies for the study of lipids. | Q34739639 | ||
Analysis of lipid experiments (ALEX): a software framework for analysis of high-resolution shotgun lipidomics data | Q35045437 | ||
Sphingolipid metabolites in inflammatory disease | Q35061720 | ||
The role of COX-2 in intestinal inflammation and colorectal cancer | Q35234704 | ||
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation | Q35645037 | ||
PPARgamma as a new therapeutic target in inflammatory bowel diseases | Q35768913 | ||
The gut microbiota modulates host amino acid and glutathione metabolism in mice | Q35811086 | ||
The Reactome pathway Knowledgebase | Q35866115 | ||
Metabolomic applications to decipher gut microbial metabolic influence in health and disease | Q35914935 | ||
KEGG as a reference resource for gene and protein annotation | Q36434599 | ||
Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer | Q36569962 | ||
Annotating cancer variants and anti-cancer therapeutics in reactome | Q37017116 | ||
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). | Q37281827 | ||
Bile acids as regulatory molecules | Q37297846 | ||
Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics | Q37309534 | ||
High-throughput shotgun lipidomics by quadrupole time-of-flight mass spectrometry | Q37415000 | ||
Hepatic lipid metabolism and non-alcoholic fatty liver disease. | Q37440137 | ||
High throughput quantitative molecular lipidomics | Q37902290 | ||
Essential fatty acids and immune response | Q38228063 | ||
Gut microbiome and lipid metabolism: from associations to mechanisms | Q38800638 | ||
Resolving microbial membership using Abundance and Variability In Taxonomy ('AVIT ). | Q39485177 | ||
Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks | Q39657662 | ||
Active efflux of bile salts by Escherichia coli | Q39845292 | ||
The gut microbiota modulates host energy and lipid metabolism in mice | Q39993460 | ||
Getting away from glucose: fanning the flames of obesity-induced inflammation | Q42110382 | ||
Lipidomics: an analysis of cellular lipids by ESI-MS. | Q42498340 | ||
Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease | Q42788496 | ||
Skeletal muscle lipid metabolism with obesity | Q44355154 | ||
Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. | Q46011025 | ||
Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury | Q46911139 | ||
Liver-specific expression of carboxylesterase 1g/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling. | Q53149954 | ||
Comprehensive quantitative determination of PUFA-related bioactive lipids for functional lipidomics using high-resolution mass spectrometry. | Q53257424 | ||
Effect of phosphatidylcholine on triacylglycerol synthesis in rat intestinal mucosa | Q68818965 | ||
Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease | Q73509678 | ||
Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system | Q79753640 | ||
Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation | Q79916437 | ||
Network-based prediction of human tissue-specific metabolism | Q81798711 | ||
iMAT: an integrative metabolic analysis tool | Q82473473 | ||
Lipidomics: new tools and applications | Q82822475 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | transcriptome | Q252857 |
microbiome | Q1330402 | ||
P304 | page(s) | 33 | |
P577 | publication date | 2017-11-07 | |
P1433 | published in | NPJ systems biology and applications | Q27727264 |
P1476 | title | Transcriptomics-driven lipidomics (TDL) identifies the microbiome-regulated targets of ileal lipid metabolism | |
P478 | volume | 3 |
Q100694558 | Gut microbial molecules in behavioural and neurodegenerative conditions |
Q94093743 | UEG Week 2018 Oral Presentations |
Search more.